Evaluation of Omalizumab From a Health Plan Perspective

OBJECTIVES: To review the pathophysiology of allergic asthma and information on the pharmacology, clinical efficacy, safety profile, and direct drug costs for omalizumab to provide a basis for a defined role of this agent in allergic asthma therapy in managed care organizations. SUMMARY: Omalizumab...

Descripción completa

Detalles Bibliográficos
Autores principales: Belliveau, Paul P., Lahoz, Monina R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2005
Materias:
Formulary Management
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438166/
https://www.ncbi.nlm.nih.gov/pubmed/16300417
http://dx.doi.org/10.18553/jmcp.2005.11.9.735

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438166/
https://www.ncbi.nlm.nih.gov/pubmed/16300417
http://dx.doi.org/10.18553/jmcp.2005.11.9.735

Ejemplares similares